1. Chromenes: potential new chemotherapeutic agents for cancer;Patil;Future Med. Chem.,2013
2. a)S.X. Cai, J.A. Drewe, S. Kasibhatla, W.E. Kemnitzer, B.Y. Tseng, C. Blais, H. Gourdeau, D. Labrecque. Substituted 4-aryl chromene as activator of caspases and inducer of apoptosis and as anti-vascular agent and the use thereof. Patent WO2008/005572 A2, 6 July 2006.
3. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions;Kemnitzer;Bioorg. Med. Chem. Lett.,2005
4. J.M.D. Gulley. (2010) A Phase I/II trial of crolibulin (EPC2407) plus cisplatin in adults with solid tumors with a focus on anaplastic thyroid cancer (ATC). Accessed 21 July 2022. http://www.clinicaltrials.gov
5. Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity;Kasibhatla;Mol. Cancer Ther.,2004